Finanzwire Finanzwire
Basculer en Français
10184 Companies
209529 Keywords
139629 Articles
111067 Press releases
Headlines Articles Press releases MAbxience Remove
  1. Home
  2. Companies
  3. MAbxience
Finanzwire
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 12/22/2025 at 22:10, 3 months 17 days ago

    FDA Approves mAbxience and Amneal's Denosumab Biosimilars

    FDA Approval Amneal Pharmaceuticals Denosumab Biosimilars MAbxience Affordable Biologics
  • PRESS RELEASE

    published on 12/22/2025 at 22:05, 3 months 17 days ago

    mAbxience and Amneal Announces FDA Approval of Denosumab Biosimilars Referencing Prolia® and XGEVA®

    mAbxience and Amneal announced FDA approval of denosumab biosimilars referencing Prolia and XGEVA, expanding affordable biologic access in the US
    FDA Approval Denosumab Biosimilars MAbxience Amneal Prolia XGEVA
    Logo of MAbxience
  • BRIEF

    published on 12/04/2025 at 09:10, 4 months 5 days ago

    MAbxience and HP Collaborate on AI in Biomanufacturing

    Artificial Intelligence Biosimilars Biomanufacturing MAbxience HP Inc.
  • PRESS RELEASE

    published on 12/04/2025 at 09:05, 4 months 5 days ago

    mAbxience and HP drive the use of artificial intelligence in biomanufacturing and biosimilar development

    mAbxience and HP collaborate on AI solution to optimize biomanufacturing and biosimilar development, enhancing predictability and efficiency. Project aims to improve patient access to biologic therapies
    AI Solution Biosimilar Development Biomanufacturing MAbxience HP
    Logo of MAbxience
Accesswire
  • Published on 04/09/2026 at 16:00, 45 minutes ago

    Banff Half Marathon Completes 2025 Emissions Assessment, Supporting Climate Action with Karbon-X

  • Published on 04/09/2026 at 14:40, 2 hours 5 minutes ago

    Silver X Delivers Production Growth During the First Quarter of 2026

  • Published on 04/09/2026 at 14:00, 2 hours 45 minutes ago

    Orogen Royalties Announces Mineral Reserve and Resource Update on Producing Ermitaño Royalty

  • Published on 04/09/2026 at 13:30, 3 hours 15 minutes ago

    Datametrex Receives $6M Purchase Order for Data Centre from Fortune 500 Conglomerate

  • Published on 04/09/2026 at 13:30, 3 hours 15 minutes ago

    ESGold Advances Toward Production and Exploration Drilling as Mill Buildout Progresses in Parallel

View all ACCESSWIRE
EQS Group
  • Published on 04/09/2026 at 15:59, 46 minutes ago

    Cairn Homes Plc: Holding(s) in Company

  • Published on 04/09/2026 at 15:57, 48 minutes ago

    Cairn Homes Plc: Holding(s) in Company

  • Published on 04/09/2026 at 15:40, 1 hour 5 minutes ago

    Form 8.3 - The Vanguard Group, Inc.: LondonMetric Property plc

  • Published on 04/09/2026 at 15:39, 1 hour 5 minutes ago

    Form 8.3 - The Vanguard Group, Inc.: Schroders plc

  • Published on 04/09/2026 at 15:39, 1 hour 6 minutes ago

    Form 8.3 - The Vanguard Group, Inc.: British Land Company plc, The

View all EQS
Les Echos
  • Published on 04/09/2026 at 15:57, 47 minutes ago

    Filing of CNP Assurances SA 2025 universal registration document and 2025 Solvency and Financial Condition Reports

  • Published on 04/09/2026 at 07:00, 9 hours 45 minutes ago

    bioMérieux Unveils its BIOFIRE® SPOTFIRE® Molecular Testing Solution for the Pharmaceutical Industry, Redefining Rapid Mycoplasma Testing

  • Published on 04/08/2026 at 18:02, 22 hours 43 minutes ago

    Publication of the 2025 Universal Registration Document

  • Published on 04/08/2026 at 17:45, 23 hours ago

    DISCLOSURE OF SHARE CAPITAL AND VOTING RIGHTS

  • Published on 04/08/2026 at 12:58, 1 day 3 hours ago

    EURAZEO IS ASSIGNED A BBB CREDIT RATING (STABLE OUTLOOK) BY S&P AND A BBB CREDIT RATING (STABLE OUTLOOK) BY FITCH

View all LES ECHOS COMFI WIRE

With finanzwire.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

Finanzwire

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

© 2026 Finanzwire

Contact Authors Cookies policy Terms and conditions Privacy policy